These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 2880944)

  • 1. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens.
    Nichols DE
    J Psychoactive Drugs; 1986; 18(4):305-13. PubMed ID: 2880944
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug discrimination studies with MDMA and amphetamine.
    Oberlender R; Nichols DE
    Psychopharmacology (Berl); 1988; 95(1):71-6. PubMed ID: 2898791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemistry and pharmacology of hallucinogens, entactogens and stimulants.
    Kovar KA
    Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():69-72. PubMed ID: 9754836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R; Nichols DE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1098-106. PubMed ID: 1979813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Spüler M; Nichols DE
    Psychopharmacology (Berl); 1989; 98(3):297-303. PubMed ID: 2568652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Information on "Ecstasy".
    Greer G; Strassman RJ
    Am J Psychiatry; 1985 Nov; 142(11):1391. PubMed ID: 2865906
    [No Abstract]   [Full Text] [Related]  

  • 8. Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons.
    Evans SM; Johanson CE
    Drug Alcohol Depend; 1986 Oct; 18(2):159-64. PubMed ID: 2877843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDMA (3,4-methylenedioxymethamphetamine): proceedings of the conference. May 17-18, 1986, Oakland, California.
    J Psychoactive Drugs; 1986; 18(4):287-379. PubMed ID: 2880942
    [No Abstract]   [Full Text] [Related]  

  • 10. The background and chemistry of MDMA.
    Shulgin AT
    J Psychoactive Drugs; 1986; 18(4):291-304. PubMed ID: 2880943
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychostimulant properties of MDMA.
    Gold LH; Geyer MA; Koob GF
    NIDA Res Monogr; 1989; 95():345-6. PubMed ID: 2577038
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW; Wing LL; Geyer MA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline.
    Kamien JB; Johanson CE; Schuster CR; Woolverton WL
    Drug Alcohol Depend; 1986 Oct; 18(2):139-47. PubMed ID: 2877841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDMA and human sexual function.
    Buffum J; Moser C
    J Psychoactive Drugs; 1986; 18(4):355-9. PubMed ID: 2880951
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of MDMA ("Ecstasy") and its optical isomers on schedule-controlled responding in mice.
    Glennon RA; Little PJ; Rosecrans JA; Yousif M
    Pharmacol Biochem Behav; 1987 Feb; 26(2):425-6. PubMed ID: 2883666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral suppression following 3,4-methylenenedioxymethamphetamine.
    Kulmala HK; Boja JW; Schechter MD
    Life Sci; 1987 Sep; 41(11):1425-9. PubMed ID: 2887995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subjective reports of the effects of MDMA in a clinical setting.
    Greer G; Tolbert R
    J Psychoactive Drugs; 1986; 18(4):319-27. PubMed ID: 2880946
    [No Abstract]   [Full Text] [Related]  

  • 18. PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA.
    Rangisetty JB; Bondarev ML; Chang-Fong J; Young R; Glennon RA
    Pharmacol Biochem Behav; 2001; 69(1-2):261-7. PubMed ID: 11420094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designer drug confusion: a focus on MDMA.
    Beck J; Morgan PA
    J Drug Educ; 1986; 16(3):287-302. PubMed ID: 2877058
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline.
    Glennon RA; Misenheimer BR
    Pharmacol Biochem Behav; 1989 Aug; 33(4):909-12. PubMed ID: 2575759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.